US pharmaceutical major Pfizer's India unit on Monday said that it has stopped selling its cough syrup Corex, after the Indian government banned it saying it was likely to pose a risk to humans. Corex is one of the 344 drug combinations the government banned on Saturday after a government panel of experts found they had "no therapeutic justification".